JP2013507382A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013507382A5 JP2013507382A5 JP2012533334A JP2012533334A JP2013507382A5 JP 2013507382 A5 JP2013507382 A5 JP 2013507382A5 JP 2012533334 A JP2012533334 A JP 2012533334A JP 2012533334 A JP2012533334 A JP 2012533334A JP 2013507382 A5 JP2013507382 A5 JP 2013507382A5
- Authority
- JP
- Japan
- Prior art keywords
- combination
- amino
- chloro
- methyl
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- WPJLXEJHHIOEGW-YOBAOWEQSA-N CN/C(/c(cc(C(N[C@@H](Cc(cc1F)ccc1F)CN)=O)[o]1)c1Cl)=C(\C=N)/Cl Chemical compound CN/C(/c(cc(C(N[C@@H](Cc(cc1F)ccc1F)CN)=O)[o]1)c1Cl)=C(\C=N)/Cl WPJLXEJHHIOEGW-YOBAOWEQSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US24980309P | 2009-10-08 | 2009-10-08 | |
| US61/249,803 | 2009-10-08 | ||
| PCT/US2010/051907 WO2011044414A1 (en) | 2009-10-08 | 2010-10-08 | Combination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013507382A JP2013507382A (ja) | 2013-03-04 |
| JP2013507382A5 true JP2013507382A5 (enExample) | 2013-11-28 |
Family
ID=43857162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012533334A Ceased JP2013507382A (ja) | 2009-10-08 | 2010-10-08 | 組合せ |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US8835450B2 (enExample) |
| EP (1) | EP2485593B1 (enExample) |
| JP (1) | JP2013507382A (enExample) |
| KR (1) | KR20120100978A (enExample) |
| CN (1) | CN102665418B (enExample) |
| AU (1) | AU2010303363B2 (enExample) |
| BR (1) | BR112012008271A2 (enExample) |
| CA (1) | CA2777085A1 (enExample) |
| EA (1) | EA022982B1 (enExample) |
| ES (1) | ES2532026T3 (enExample) |
| IL (1) | IL218999A (enExample) |
| MX (1) | MX2012004139A (enExample) |
| PL (1) | PL2485593T3 (enExample) |
| PT (1) | PT2485593E (enExample) |
| WO (1) | WO2011044414A1 (enExample) |
| ZA (1) | ZA201202494B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104302275A (zh) * | 2012-04-24 | 2015-01-21 | 葛兰素史密斯克莱知识产权（第2号）有限公司 | 类固醇反应性皮肤病的治疗方法 |
| AU2013334945A1 (en) * | 2012-10-22 | 2015-04-23 | Novartis Ag | Combination |
| BR112015008924A2 (pt) * | 2012-10-22 | 2017-07-04 | Glaxosmithkline Llc | combinação |
| CN104109159A (zh) | 2013-04-17 | 2014-10-22 | 杭州普晒医药科技有限公司 | 苯磺酰胺噻唑化合物的新晶型及其制备方法 |
| CN104540822B (zh) * | 2013-07-08 | 2016-08-31 | 杭州普晒医药科技有限公司 | 达拉菲尼甲磺酸盐的晶型及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE309205T1 (de) * | 1999-01-13 | 2005-11-15 | Warner Lambert Co | Benzenesulfonamid-derivative und ihre verwendung als mek-inhibitoren |
| IL149150A0 (en) * | 1999-11-22 | 2002-12-01 | Smithkline Beecham Plc | 2-(4-(6-methoxy-naphthalene-2-yl)-5-pyridin-4-yl-1h-imidazole-2-yl)-2-methyl-derivatives, pharmaceutical compositions comprising them and use thereof as tie2 receptor kinase inhibitors |
| WO2004080972A1 (en) * | 2003-03-12 | 2004-09-23 | Vertex Pharmaceuticals Incorporated | Pirazole modulators of atp-binding cassette transporters |
| DE102004018198A1 (de) * | 2004-04-15 | 2005-11-03 | Merck Patent Gmbh | Sulfonamide |
| WO2005121142A1 (en) * | 2004-06-11 | 2005-12-22 | Japan Tobacco Inc. | 5-amino-2,4,7-trioxo-3,4,7,8-tetrahydro-2h-pyrido’2,3-d! pyrimidine derivatives and related compounds for the treatment of cancer |
| EP1981884B1 (en) * | 2006-01-18 | 2012-06-13 | Amgen, Inc | Thiazole compounds as protein kinase b (pkb) inhibitors |
| UY30892A1 (es) | 2007-02-07 | 2008-09-02 | Smithkline Beckman Corp | Inhibidores de la actividad akt |
| UA103319C2 (en) * | 2008-05-06 | 2013-10-10 | Глаксосмитклайн Ллк | Thiazole- and oxazole-benzene sulfonamide compounds |
-
2010
- 2010-10-08 KR KR1020127011758A patent/KR20120100978A/ko not_active Abandoned
- 2010-10-08 WO PCT/US2010/051907 patent/WO2011044414A1/en not_active Ceased
- 2010-10-08 EP EP10822733.1A patent/EP2485593B1/en active Active
- 2010-10-08 CN CN201080055873.2A patent/CN102665418B/zh not_active Expired - Fee Related
- 2010-10-08 BR BR112012008271A patent/BR112012008271A2/pt not_active IP Right Cessation
- 2010-10-08 AU AU2010303363A patent/AU2010303363B2/en not_active Ceased
- 2010-10-08 ES ES10822733.1T patent/ES2532026T3/es active Active
- 2010-10-08 EA EA201270526A patent/EA022982B1/ru not_active IP Right Cessation
- 2010-10-08 JP JP2012533334A patent/JP2013507382A/ja not_active Ceased
- 2010-10-08 CA CA2777085A patent/CA2777085A1/en not_active Abandoned
- 2010-10-08 MX MX2012004139A patent/MX2012004139A/es active IP Right Grant
- 2010-10-08 US US13/500,241 patent/US8835450B2/en not_active Expired - Fee Related
- 2010-10-08 PT PT108227331T patent/PT2485593E/pt unknown
- 2010-10-08 PL PL10822733T patent/PL2485593T3/pl unknown
-
2012
- 2012-04-02 IL IL218999A patent/IL218999A/en not_active IP Right Cessation
- 2012-04-05 ZA ZA2012/02494A patent/ZA201202494B/en unknown
-
2014
- 2014-08-11 US US14/456,180 patent/US9402846B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013509429A5 (enExample) | ||
| JP2014505107A5 (enExample) | ||
| JP2015536964A5 (enExample) | ||
| RU2015121367A (ru) | Фармацевтическая комбинация, содержащая ингибитор b-raf и ингибитор деацетилазы гистонов, и ее применение при лечении пролиферативных заболеваний | |
| JP2012255026A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| JP2012512907A5 (enExample) | ||
| JP2014532647A5 (enExample) | ||
| JP2012502015A5 (enExample) | ||
| JP2015508103A5 (enExample) | ||
| JP2013522326A5 (enExample) | ||
| JP2012193216A5 (enExample) | ||
| JP2013508279A5 (enExample) | ||
| JP2016040288A5 (enExample) | ||
| JP2014528901A5 (enExample) | ||
| JP2014503593A5 (enExample) | ||
| JP2013507382A5 (enExample) | ||
| JP2013507442A5 (enExample) | ||
| JP2015503596A5 (enExample) | ||
| JP2012522841A5 (enExample) | ||
| JP2015517523A5 (enExample) | ||
| JP2015527374A5 (enExample) | ||
| JP2013544892A5 (enExample) | ||
| CA2847011A1 (fr) | Schema d'administration du n-hydroxy-4-{2-[3-(n,n-dimethylaminomethyl)benzofuran-2-ylcarbonylamino]ethoxy}benzamide | |
| JP2013507383A5 (enExample) |